Search results
Results from the WOW.Com Content Network
In 2009 Streeck was promoted to Instructor in Medicine and in 2011 to Assistant Professor at Harvard Medical School. In September 2012 he was recruited to the United States Military HIV Research Program, Bethesda, where he became the Chief of the Cellular Immunology Section as well as assistant professor at the Uniformed Services University of Health Sciences and adjunct faculty of the ...
The Summit has been a catalyst for partnerships, and the setting of several global health announcements. [3] In 2007, during a speech [4] at the Summit, Margaret Chan, Director-General of the World Health Organization, publicized “a new initiative to establish a world stockpile of vaccines to prepare for the threat of pandemic influenza.” [5] At the Summit in 2009, Sanofi bolstered that ...
The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus (the first being the 1918–1920 Spanish flu pandemic and the second being the 1977 Russian flu).
Vaccine. 29 (6): 1135– 1138. doi: 10.1016/j.vaccine.2010.11.042. PMID 21115061. Vaccines for pandemic (H1N1) 2009. World Health Organization (WHO). Vaccine against 2009 H1N1 Influenza Virus. Centers for Disease Control and Prevention (CDC). 2009 influenza A (H1N1) pandemic. European Centre for Disease Prevention and Control (ECDC). Summaries ...
The successor to PDVI, the Dengue Vaccine Initiative was an IVI-led consortium with the World Health Organization, the Sabin Vaccine Institute, the Initiative for Vaccine Research (IVR), and the International Vaccine Access Center (IVAC) at Johns Hopkins University. DVI continued the work of PDVI and focused on laying the groundwork for dengue ...
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
use of vaccines and other immunobiologic agents in clinical practice or preventive medicine; clinical or laboratory vaccine research; assessment of vaccine efficacy and safety; consumer perspectives and/or social and community aspects of immunization programs; at least one member must be an expert in this category.